Glycoxidised LDL Induced the Upregulation of Axl Receptor Tyrosine Kinase and Its Ligand in Mouse Mesangial Cells

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Kim, Young Sook ^a   Jung, Dong Ho ^a   Sohn, Eunjin ^a   Kim, Junghyun ^a   Kim, Jin Sook ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AXL RECEPTOR TYROSINE KINASE; DNA; GLUCOSE; GLYCOXIDIZED LOW DENSITY LIPOPROTEIN; GROWTH ARREST SPECIFIC PROTEIN 6; MESSENGER RNA; METHYLGLYOXAL; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN ANTIBODY; PROTEIN TYROSINE KINASE; ROTTLERIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AXL GENE; CONTROLLED STUDY; CYTOKINE RELEASE; DIABETIC NEPHROPATHY; DNA MICROARRAY; EXTRACELLULAR MATRIX; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE SILENCING; GO LDL GENE; IMMUNOHISTOCHEMISTRY; MALE; MESANGIUM CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATION; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ACETOPHENONES; ANIMALS; BENZOPYRANS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; GENE EXPRESSION REGULATION; GLUCOSE; GLYCOSYLATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPOPROTEINS, LDL; MALE; MESANGIAL CELLS; MICE; OXIDATION-REDUCTION; PROTO-ONCOGENE PROTEINS; PYRUVALDEHYDE; RATS; RATS, ZUCKER; RECEPTOR PROTEIN-TYROSINE KINASES; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1;

RATTUS;

EID: 84870576238     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050297     Document Type: Article

References (28)

1. Krolewski M, Eggers PW, Warram JH, (1996) Magnitude of end-stage renal disease in IDDM: a 35 year follow-up study. Kid Int 50(6): 2041-2046.
2. Nagai K, Matsubara T, Mima A, Sumi E, Kanamori H, et al. (2005) Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy. Kid Int 68(2): 552-561.
3. Lyons TJ, (1993) Glycation and oxidation: a role in the pathogenesis of atherosclerosis. Am J Cardiol 71(6): 26B-31B.
4. Brown MS, Goldstein JL, (1986) A receptor-mediated pathway for cholesterol homeostasis. Science 232(4746): 34-47.
5. Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, et al. (1996) Expression monitoring by hybridization to high-density oligonucleotide arrays. Nature Biotechnol 14(13): 1675-1680.
6. Sreekumar R, Halvatsiotis P, Schimke JC, Nair KS, (2002) Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment. Diabetes 51(6): 1913-1920.
7. Rankin EB, Fuh KC, Taylor TE, Krieg AJ, Musser M, et al. (2010) AXL is an essential factor and therapeutic target for metastatic ovarian cancer. Cancer Res 70(19): 7570-7579.
8. Linger RM, Keating AK, Earp HS, Graham DK, (2010) Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors. Expert Opin Ther Targets. 14(10): 1073-1090.
9. Cavet ME, Smolock EM, Ozturk OH, World C, Pang J, et al. (2008) Gas6-axl receptor signaling is regulated by glucose in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 28(5): 886-891.
10. D'Arcangelo D, Ambrosino V, Giannuzzo M, Gaetano C, Capogrossi M, (2006) Axl receptor activation mediates laminar shear stress anti-apoptotic effects in human endothelial cells. Cardiovasc Res 71(4): 754-763.
11. Yanagita M, Ishii K, Ozaki H, Arai H, Nakano T, et al. (1999) Mechanism of inhibitory effect of warfarin on mesangial cell proliferation. J Am Soc Nephrol 10(12): 2503-2509.
12. Yanagita M, Arai H, Ishii K, Nakano T, Ohashi K, et al. (2001) Gas6 regulates mesangial cell proliferation through Axl in experimental glomerulonephritis. Am J Pathol 158(4): 1423-1432.
13. Nagai K, Arai H, Yanagita M, Matsubara T, Kanamori H, et al. (2003) Growth arrest-specific gene 6 is involved in glomerular hypertrophy in the early stage of diabetic nephropathy. J Biol Chem 278(20): 18229-18234.
14. Lee HS, Kim BC, Kim YS, Choi KH, Chung HK, (1996) Involvement of oxidation in LDL-induced collagen gene regulation in mesangial cells. Kid Int 50(5): 1582-1590.
15. Duell PB, Oram JF, Bierman EL, (1990) Nonenzymatic glycosylation of HDL resulting in inhibition of high-affinity binding to cultured human fibroblasts. Diabetes. 39(10): 1257-1263.
16. Habeeb AF, (1966) Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. Anal Biochem 14(3): 328-336.
17. Kim YS, Jung DH, Kim NH, Lee YM, Kim JS, (2007) Effect of magnolol on TGF-beta1 and fibronectin expression in human retinal pigment epithelial cells under diabetic conditions. Eur J Pharmacol 562(1-2): 12-19.
18. Yanagita M, Arai H, Nakano T, Ohashi K, Mizuno K, et al. (2001) Gas6 induces mesangial cell proliferation via latent transcription factor STAT3. The J Biol Chem 276(45): 42364-42369.
19. Maquoi E, Voros G, Carmeliet P, Collen D, Lijnen HR, (2005) Role of Gas-6 in adipogenesis and nutritionally induced adipose tissue development in mice. Arterioscler Thromb Vasc Biol 25(5): 1002-1007.
20. Knott HM, Brown BE, Davies MJ, Dean RT, (2003) Glycation and glycoxidation of low-density lipoproteins by glucose and low-molecular mass aldehydes. Formation of modified and oxidized particles. Eur J Biochem/FEBS. 270(17): 3572-3582.
21. Arai H, Nagai K, Doi T, (2008) Role of growth arrest-specific gene 6 in diabetic nephropathy. Vitam Horm 78: 375-392.
22. Chen S, Jim B, Ziyadeh FN, (2003) Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up. Semin Nephrol 23(6): 532-543.
23. Fourcot A, Couchie D, Chobert MN, Zafrani ES, Mavier P, et al. (2011) Gas6 deficiency prevents liver inflammation, steatohepatitis, and fibrosis in mice. Am J Physiol Gastrointest Liver Physiol 300(6): G1043-1053.
24. Menne J, Meier M, Park JK, Haller H, (2009) Inhibition of protein kinase C in diabetic nephropathy-where do we stand? Nephrol Dial Transplant 24(7): 2021-2023.
25. Lee TS, Saltsman KA, Ohashi H, King GL, (1989) Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications. Proc Natl Acad Sci USA 86(13): 5141-5145.
26. Menne J, Park JK, Boehne M, Elger M, Lindschau C, et al. (2004) Diminished loss of proteoglycans and lack of albuminuria in protein kinase C-alpha-deficient diabetic mice. Diabetes. 53(8): 2101-2109.
27. Geraldes P, King GL, (2010) Activation of protein kinase C isoforms and its impact on diabetic complications. Circ Res 106(8): 1319-1331.
28. Sataranatarajan K, Lee MJ, Mariappan MM, Feliers D, (2008) PKCdelta regulates the stimulation of vascular endothelial factor mRNA translation by angiotensin II through hnRNP K. Cell Signal. 20(5): 969-977.